Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AdisInsight Datasets - Snowflake

Overview

The AdisInsight Drugs & Trials datasets, available via Snowflake, deliver a unified, scientifically curated view of global drug development and clinical research activity. Powered by Springer Nature’s AdisInsight platform, these datasets provide continuously updated intelligence across the full pharmaceutical lifecycle. The underlying data mirrors the same trusted content available via AdisInsight APIs, enriched with expert validation and structured for scalable analytics, machine learning, and enterprise data integration.

Data Coverage

  • Drugs Dataset - Comprehensive Drug Pipeline Intelligence

    The Drugs dataset provides detailed profiles of drug programs worldwide, capturing the complete lifecycle of therapeutic development.

    Key Data Elements
    • Development Status Indication, patient segment, phase, country, formulation
    • Organizations & Partnerships Developers, collaborators, licensing relationships
    • Scientific & Technical Data Mechanism of action, biomarkers, chemical properties
    • Commercial Intelligence Brand names, market status, stock symbols
    • Development History Milestones from discovery to approval
    • Future Events & Insights Anticipated regulatory or clinical milestones

    These profiles "tell the ongoing story of a drug's progress" across discovery, preclinical and clinical stages through to approval.

    Value for Users
    • Identify emerging therapies and innovation trends
    • Evaluate competitor pipelines and positioning
    • Support business development, licensing, and investment decisions
    • Discover drug repurposing opportunities and therapeutic targets

  • Trials Dataset - Global Clinical Trial Intelligence

    The Trials dataset captures detailed information on clinical studies, enabling a deep understanding of trial design, execution, and outcomes.

    Key Data Elements
    • Trial Design & Structure Study type, endpoints, treatment arms, methodologies
    • Patient & Population Data Demographics, inclusion/exclusion criteria
    • Operational Details Locations, sponsors, investigators, timelines
    • Clinical Outcomes Efficacy and safety summaries
    • Trial Lifecycle Tracking From planning and recruitment to completion and results

    These profiles track trials "from planning to completion" and summarize key efficacy and safety outcomes.

    Value for Users
    • Map the global clinical trial landscape
    • Identify treatment gaps and unmet medical needs
    • Optimize clinical trial design and strategy
    • Benchmark competitor studies and outcomes

Business Use Cases

  • Competitive and Business Intelligence - Understand which competitors are progressing fastest through regulatory pathways, which are targeting novel treatment mechanisms, and which are focused on specific patient segments. See how key clinical trials are advancing, which subjects are being recruited, and what safety and efficacy results being reported.
  • Portfolio Strategy and Product Planning - Assess the market for new treatment trends, patient segmentation, and market attractiveness for a disease area. Identify future competitors and predict when and where they will be available. Evaluate the strengths and weaknesses of your product compared to competitor products in development. Discover new development programs and track updates to competitors over time.
  • Business Development and Licensing - Identify opportunities meeting the strategic needs of the organization in a particular disease area. Quickly build go/no-go list by eliminating or promoting R&D assets by drug class, biologic target, mechanism of action, developer, or patent life. Identify which R&D assets are meeting clinical trial endpoints. Compare R&D assets based on clinical results of efficacy and safety. Utilize financial forecasts to size the value of the market. Compare your deal against prior deals for similar assets in terms of value and structure.
  • Research and Development - Identify opportunities for development in the treatment of diseases addressing an unmet need or new target market due to available options or deficiency in efficacy and safety. Support commercial go/no-go decisions based on scientific evidence of efficacy and safety. Determine "druggable" therapeutic target directly involved in the disease process and the molecular mechanism address the target. Uncover previous successes and failures to support development of your clinical trial objectives and end point goals. Find opportunities to repurpose drugs in new indications or patient populations.
  • Equity Research and Investment - Use drug development information as an alternative data source to determine trading strategies based on back testing historical drug development information against changes in the market. Identify and assess potential opportunities by seeing the full picture of a company’s asset performance or a disease landscape, with relevant information on drug development and clinical trials. Add value to equity research and recommendations by incorporating clinical successes and failures for pivotal trials required for regulatory advancement to the next step in the drug development process. Easily find the data you need to support business and investment decisions based on the most compelling scientific and commercial information.
Back to top